Genetic insights help personalize
cancer risk and management


Hereditary cancer genetic testing informs on personalized cancer risk and supports preventive care strategies throughout a woman’s health journey. Genetic test results can empower you and your patients with critical health information to modify, guide, and optimize medical management.


Healthcare providers recognize the importance of genetics in helping patients make decisions about their health


In our latest webcast, medical experts in women’s health weigh in on why genetic testing matters to patients and how knowing their risk can help them take charge of their future.

“About 24% of women who go to a gynecologist office are eligible for cancer susceptibility gene testing. We need to be aware of these patients coming into our office because medical management changes according to their risk.

– Elizabeth Etkin-Kramer, M.D., FACOG, Associate Professor in OB/GYN at FIU Herbert Wertheim College of Medicine

“As more options are available, knowing hereditary risk predisposition early on can help patients with better family planning.”

– Matthew Lederman, Reproductive Endocrinologist and Infertility Specialist at RMA of New York

“One of the most important things you can do for your patients is to take their family history to see if they are candidates for hereditary cancer risk testing.”

– Jill Chisholm, APNG President and Founder of GeneScreen and Chief Medical Officer of Synergenomics


Listen to the webcast

“CATCHING CANCER EARLY: Assessing the need for and effectively
implementing a care delivery model for hereditary cancer.”

Access the webcast here

Knowing a patient’s hereditary cancer risk can create a more personalized plan of action


Depending on the genetic change identified, guideline-driven and actionable medical recommendations may include:

Earlier and increased screenings

Risk-reducing surgeries or medications

Fertility and family planning

Proactive testing and support for relatives

Targeted treatment options


Sema4 Signal Hereditary Cancer


Advanced testing of up to 112 curated genes with best-in-class services to support you and your patients at every step of the way:

  • Multi-cancer High Prevalence panel for increased detection rates
  • Digital patient identification tools and video-based pre-test education
  • Extensive network coverage and preauthorization support
  • Proactive post-test telegenic counseling for all patients with non-negative results
  • Patient-friendly reporting, cascade testing, and family studies program



Ready to start?

Ordering hereditary cancer testing through Sema4 is simple. We accept blood and saliva samples and provide specimen collection kits, in-office or directly to the patient’s home. Feel free to call us at 833-486-6260 or fill out the form below and we’ll schedule a time to discuss your needs.